Arca Biopharma Inc (ABIO): Refined And Ready To Rebound: We Like What We ... Seeking Alpha Secondary endpoints included cardiovascular death, hospitalization for any reason, hospitalization for HF, myocardial infarction, quality of life, and a composite of death or heart transplantation. A total of 2,708 patients were randomized into the ... |
